Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13

Trial Status

Completed1
Other2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT05487651Phase 1Unknown
Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies
ALL, Adult B CellALL, ChildhoodB-cell Leukemia+4 more
PrincipalinvestigatorStart date: 2022-10-01
NCT03774654Phase 1Active Not Recruiting
CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)
Refractory B-Cell Non-Hodgkin LymphomaRefractory B-Cell Small Lymphocytic LymphomaRelapsed Adult ALL+2 more
PrincipalinvestigatorStart date: 2020-04-14
NCT00709033Phase 1Completed
T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL
Chronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinLymphoma, B-CellCLL/SLL
Similarity Score6%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Lymphoma, B-CellLeukemia, Lymphocytic, Chronic, B-CellLymphoma, Non-Hodgkin

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-CellLymphoma, B-Cell

Worked with same sponsors:

Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of Medicine+1 more
Similarity Score6%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Lymphoma, B-CellLeukemia, Lymphocytic, Chronic, B-Cell

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-Cell
Similarity Score4%

David Cunningham

Royal Marsden NHS Foundation Trust

Related
13 trials

Shared therapeutic areas:

Lymphoma, B-CellLymphoma, Non-Hodgkin
Similarity Score4%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-Cell
Similarity Score4%

Weidong Han, Ph.D

Biotherapeutic Department, Chinese PLA General Hospital

Related
12 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinLymphoma, B-Cell
Similarity Score4%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Non-Hodgkin
Similarity Score4%

Pier Luigi Zinzani, MD

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Related
14 trials

Shared therapeutic areas:

DLBCL - Diffuse Large B Cell LymphomaLymphoma, Non-Hodgkin
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05487651Phase 1PrincipalInvestigator

Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies

ALL, Adult B CellALL, ChildhoodB-cell Leukemia+4 more
Unknown
NCT03774654Phase 1PrincipalInvestigator

CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)

Refractory B-Cell Non-Hodgkin LymphomaRefractory B-Cell Small Lymphocytic LymphomaRelapsed Adult ALL+2 more
Active Not Recruiting
NCT00709033Phase 1PrincipalInvestigator

T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL

Chronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma
Completed

All 3 trials loaded